2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one
C21H26N4O2S — CID 143504885
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one
2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one (PubChem CID 143504885) has the molecular formula C21H26N4O2S and a molecular weight of 398.53 g/mol. Its IUPAC name is 2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one.
Molecular Properties
| Compound Name | 2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one |
|---|---|
| PubChem CID | 143504885 |
| Molecular Formula | C21H26N4O2S |
| Molecular Weight | 398.53 g/mol |
| Exact Mass | 398.18 |
| IUPAC Name | 2-[4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl]-5,6,7,8-tetrahydro-4H-1,3-oxazonin-9-one |
| SMILES | CN1CCN(c2nc(-c3ccc(/C4=N/CCCCCC(=O)O4)cc3)cs2)CC1 |
| InChI | InChI=1S/C21H26N4O2S/c1-24-11-13-25(14-12-24)21-23-18(15-28-21)16-6-8-17(9-7-16)20-22-10-4-2-3-5-19(26)27-20/h6-9,15H,2-5,10-14H2,1H3/b22-20- |
| InChIKey | VETXKWSRMPQQPM-XDOYNYLZSA-N |
| XLogP | 3.43 |
| TPSA | 58.03 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 398.53 |
| LogP ≤ 5 | 3.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143504885 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.